We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Greene County Bancorp
GCBC
$589M
| $630K | ﹤0.01% |
21,946
| – | – |
|
2777
Groupon
GRPN
$1.02B
| $630K | ﹤0.01% |
73,414
-6,207
| -8% | -$48.1K |
|
2778
Northeast Bank
NBN
$1.14B
| $630K | ﹤0.01% |
14,974
-3,294
| -18% | -$138K |
|
2779
EverQuote
EVER
$906M
| $629K | ﹤0.01% |
42,645
-13,695
| -24% | -$129K |
|
|
ENFN
2780
DELISTED
Enfusion, Inc.
ENFN
| $626K | ﹤0.01% |
64,796
-4,359
| -6% | -$49.1K |
|
2781
iRadimed
IRMD
$1.18B
| $625K | ﹤0.01% |
22,114
-5,128
| -19% | -$147K |
|
|
BRT
2782
BRT Apartments
BRT
$271M
| $622K | ﹤0.01% |
31,682
-30,028
| -49% | -$616K |
|
2783
Veritone
VERI
$122M
| $621K | ﹤0.01% |
117,040
+35,477
| +43% | +$227K |
|
|
FINV
2784
FinVolution Group
FINV
$1.15B
| $615K | ﹤0.01% |
123,900
-36,800
| -23% | -$173K |
|
2785
Diageo
DEO
$53.6B
| $610K | ﹤0.01% |
3,424
+472
| +16% | +$82.8K |
|
2786
Preformed Line Products
PLPC
$2.28B
| $607K | ﹤0.01% |
7,288
-1,663
| -19% | -$137K |
|
2787
BARK
BARK
$101M
| $606K | ﹤0.01% |
20,353
-2,687
| -12% | -$89.4K |
|
2788
ESS Tech
GWH
$18.9M
| $605K | ﹤0.01% |
16,596
-260
| -2% | -$13.3K |
|
2789
First Western Financial
MYFW
$306M
| $604K | ﹤0.01% |
21,458
-10,318
| -32% | -$288K |
|
2790
Rackspace Technology
RXT
$1.24B
| $602K | ﹤0.01% |
204,071
-22,564
| -10% | -$95.3K |
|
|
KNTE
2791
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $602K | ﹤0.01% |
98,706
-12,347
| -11% | -$101K |
|
|
ZIMV
2792
DELISTED
ZimVie
ZIMV
| $598K | ﹤0.01% |
64,096
-40,603
| -39% | -$355K |
|
2793
Advantage Solutions
ADV
$361M
| $597K | ﹤0.01% |
11,475
-965
| -8% | -$60.6K |
|
2794
VistaGen Therapeutics
VTGN
$12.8M
| $597K | ﹤0.01% |
18,587
-1,136
| -6% | -$4.28K |
|
2795
Ocular Therapeutix
OCUL
$2.02B
| $594K | ﹤0.01% |
211,160
-46,102
| -18% | -$153K |
|
|
GNTY
2796
DELISTED
Guaranty Bancshares
GNTY
| $590K | ﹤0.01% |
17,035
-8,372
| -33% | -$297K |
|
|
MAGN
2797
Magnera Corp
MAGN
$460M
| $589K | ﹤0.01% |
11,775
-12,812
| -52% | -$523K |
|
2798
eGain
EGAN
$201M
| $587K | ﹤0.01% |
64,941
-7,968
| -11% | -$65.6K |
|
2799
Lifecore Biomedical
LFCR
$190M
| $586K | ﹤0.01% |
90,357
-13,508
| -13% | -$111K |
|
2800
Quantum-Si Incorporated
QSI
$177M
| $586K | ﹤0.01% |
320,303
-45,098
| -12% | -$116K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.